Tag Archives: coronary artery disease
Nickel free, built-in nanotubular drug eluting stents
Coronary Artery Disease is a common cause of heart failure. Coronary Artery Disease (CAD) is caused by the accumulation of lipids and fats within an injured arteries’ walls and restricts the blood flow to the heart muscle
A new drug to improve drug-eluting stents in coronary artery disease
Patients with symptomatic coronary artery disease often receive stent treatment in obstructed coronary arteries of the heart. Even though current generation drug-eluting stents perform very well in the short-term, concerns still exist about their long-term efficacy due
Memory process in patients with ischemic left ventricular dysfunction
Heart failure is a complex syndrome characterized by hemodynamic and neuro-hormonal alterations. In recent literature a relationship between heart failure and the presence of cognitive disorders, in particular in the domain of the attentional-executive functions, was reported
EGCg-AuNPs Nanotherapeutics – as an alternative Green Nanotechnology approach for treating cardiovascular diseases
Cardiovascular diseases are the leading cause of morbidity and mortality in the United States and globally. However, despite remarkable technological advances, significant limitations remain in stent-based treatment. Therefore, it is important to develop selective and effective therapeutics
Does the number of platelets affect outcome in patients with acute myocardial infarction?
Coronary artery atherosclerotic disease (CAD) is the most prevalent disease in industrialized countries. Acute ST-elevation myocardial infarction (STEMI) results from sudden obstruction of a coronary artery causing abrupt interruption of blood flow to the myocardium. Nowadays, urgent
Nuclear cardiac imaging: the “old grandma” has still something to say
Ischemic heart disease (IHD) remains one of the most relevant predictors of overall patients’ mortality and a major determinant of sanitary and social costs. Different strategies have been proposed for the early diagnosis of myocardial ischemia, a
A better way to measure heart disease risk for an overweight society
Low density lipoprotein (LDL) cholesterol or the “bad cholesterol” is an established measure of cardiovascular risk. LDL particles interact with the lining of the blood vessel and contribute to cholesterol loading in the arterial wall. Continued buildup
